Hope for ALS patients denied entry to clinical trials
NCT ID NCT05597436
Summary
This program provided access to an experimental ALS treatment called SLS-005 for patients who couldn't join regular clinical trials. Approximately 70 participants received weekly intravenous infusions of trehalose for up to 24 weeks. The goal was to offer this investigational treatment to patients with ALS who had limited other options available to them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barrow Neurological Institute
Phoenix, Arizona, 85013, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
George Washington University
Washington D.C., District of Columbia, 20052, United States
-
Holy Cross Hospital - Phil Smith Neuroscience Institute
Fort Lauderdale, Florida, 33308, United States
-
Hospital for Special Care
New Britain, Connecticut, 06053, United States
-
Lehigh Valley Hospital
Allentown, Pennsylvania, 18105, United States
-
Nova Southeastern University
Fort Lauderdale, Florida, 33328, United States
-
SUNY Upstate Medical University
Syracuse, New York, 13210, United States
-
Saint Alphonsus Regional Medical Center
Boise, Idaho, 83706, United States
-
Sean M. Healey & AMG Center for ALS Neurological Clinical Research Institute, Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Spectrum Health/Corewell Health
Grand Rapids, Michigan, 49503, United States
-
Texas Neurology, P.A.-Neal Site:769
Dallas, Texas, 75206, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of California, Irvine
Orange, California, 92697, United States
-
University of California, San Francisco
San Francisco, California, 94115, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
-
University of Maryland School of Medicine
Baltimore, Maryland, 21201, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
Virginia Commonwealth University Clinical Research Unit
Richmond, Virginia, 23298, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.